- In Poland at the moment we have access to all the drugs that are currently registered in the world.
- Patients with multiple sclerosis are young people. The disease will be with them for many years, so treatment needs to be p...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
Prof. Monika Adamczyk-Sowa: MS drug program is a milestone, but some modifications needed
Published May 29, 2023 11:43
